Literature DB >> 11997175

Conserved mammalian gonadotropin-releasing hormone receptor carboxyl terminal amino acids regulate ligand binding, effector coupling and internalization.

Shaun P Brothers1, Jo Ann Janovick, Guadalupe Maya-Nunez, Anda Cornea, Xin-Bing Han, P Michael Conn.   

Abstract

The mammalian gonadotropin-releasing hormone receptor (GnRHR), with 327 amino acids, is among the smallest G protein coupled receptors identified. Absent from this receptor is the cytoplasmic tail, characteristic of other members of this superfamily, which frequently mediates desensitization and down-regulation. The fifteen carboxyl terminal residues in the mammalian GnRHR are absolutely conserved, suggesting important roles for these residues. In the current study, mutations of the mammalian GnRHR were made to study the carboxyl terminus. The receptor mutant GnRHR(Ser(326)Ala) was reduced in ligand affinity (117% reduction compared to wild type (wt)), while receptor numbers and internalization remained unchanged. GnRHR(Ser(326)Tyr) was decreased in effector coupling, while ligand affinity remained unchanged compared to wt. These studies also show that, while mutation of Ser(326) caused a change in ligand binding and effector coupling, truncation at this residue (GnRHR[des(326-327)]) had no measurable effect on GnRHR ligand binding, effector coupling or internalization, functions which appear to require different structural determinants than expression and routing. Removal of all three carboxyl terminal residues (Phe(325), Ser(326) and Leu(327)) or mutation of the receptor (GnRHR[Phe(325)Ala]) caused a complete loss of measurable ligand binding and effector coupling, clearly suggesting an unexplained role for Phe(325).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997175     DOI: 10.1016/s0303-7207(02)00040-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

Review 2.  Small peptide recognition sequence for intracellular sorting.

Authors:  Kailash N Pandey
Journal:  Curr Opin Biotechnol       Date:  2010-10       Impact factor: 9.740

3.  Salt bridges overlapping the gonadotropin-releasing hormone receptor agonist binding site reveal a coincidence detector for G protein-coupled receptor activation.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; P Michael Conn
Journal:  J Pharmacol Exp Ther       Date:  2011-04-28       Impact factor: 4.030

4.  Salt bridge integrates GPCR activation with protein trafficking.

Authors:  Jo Ann Janovick; P Michael Conn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 5.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

6.  Species sequence differences determine the interaction of GnRH receptor with the cellular quality control system.

Authors:  Alejandro Cabrera-Wrooman; Jo Ann Janovick; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-07-24       Impact factor: 4.102

7.  Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity.

Authors:  Emery Smith; Jo Ann Janovick; Thomas D Bannister; Justin Shumate; Vadivel Ganapathy; Louis Scampavia; Timothy P Spicer
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 8.  Functional roles of short sequence motifs in the endocytosis of membrane receptors.

Authors:  Kailash N Pandey
Journal:  Front Biosci (Landmark Ed)       Date:  2009-06-01

Review 9.  Endocytosis and Trafficking of Natriuretic Peptide Receptor-A: Potential Role of Short Sequence Motifs.

Authors:  Kailash N Pandey
Journal:  Membranes (Basel)       Date:  2015-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.